Update on Drug-Induced Depression in the Elderly
References (99)
- et al.
Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial
Psyrhoneuroe ndocrinology
(2003) - et al.
Mood effect of raloxifene in postmenopausal women
Maturitas
(2002) - et al.
Effects of lovastatin on cognitive function and psychological wellbeing
Am J Med.
(2000) - et al.
Effects of raloxifene on mood, sleep, libido and cognitive function in postmenopausal healthy women: A pilot study
Maturitas
(2004) - et al.
Raloxifene hydrochloride, a selective estrogen receptor modulator: Safety assessment of effects on cognitive function and mood in postmenopausal women
Psychoneuroendocrinology
(1999) - et al.
The effects of propranolol on cognitive function and quality of life: A randomized trial among patients with diastolic hypertension
Am J Med.
(2000) - et al.
Cardiovascular drug prescriptions and risk of depression in diabetic patients
J Clin Epidemiol
(1999) - et al.
Raloxifene and estrogen effects on quality of life in healthy postmenopausal women: A placebo-controlled randomized trial
Obstet Gynecol
(2000) - et al.
A randomised, double-blind trial comparing raloxifene HCl and continuous combined hormone replacement therapy in postmenopausal women: Effects oncompliance and quality of life
BJOG
(2002) - et al.
Mood disorders and medical illness: A major public health problem
Biol Psychiatry
(2003)
Epidemiology of comorbid coronary artery disease and depression
Biol Psychiatry
Propranolol and depression
Lancet
Digitalis and beta-blocking agents: Effects on depression following myocardial infarction
Am Heart J
Treatment of recurrent unipolar major depression with captopril
Biol Psychiatry
Long-term statin use and psychological well-being
J Am Coll Cardiol
Medication use and major depressive syndrome in a community population
Compr Psychiatry
Depression, somatization and steroid use in chronic obstructive pulmonary disease
Int J Nurs Stud.
A meta-analysis of the effect of hormone replacement therapy upon depressed mood
Psychoneuroendocrinology.
Concomitant prescribing of benzodiazepines during antidepressant therapy in the elderly
J Clin Epidemiol
Development and validation of a geriatric depression screening scale: A preliminary report
J Psychiatr Res.
Cornell Scale for Depression in Dementia
Biol Psychiatry
Interferon-induced depression: Strategies in treatment
Prog Neuropsycbopharmacol Biol Psychiatry
Epidemiology and diagnosis of depression in late life
J Clin Psychiatry
Diagnostic and Statistical Manual of Mental Disorders
Depression in late life: Review and commentary
J Gerontol A Biol Sci Med Sci
Recent patterns of medication use in the ambulatory adult population of the United States: The Slone survey
JAMA
National estimates of medication use in nursing homes: Findings from the 1997 Medicare Current Beneficiary Survey and the 1996 Medical Expenditure Survey
J Am Geriatr Soc
Drug-induced depression
Psychother Psychosong
Drug-induced depression. Incidence, avoidance and management
Drug Saf.
Drug-induced depression in the aged. What can be done?
Drugs Aging
Drug-induced depression
Pharmacol Toxicol
Drug or symptom-induced depression in men treated with alpha 1-blockers for benign prostatic hyperplasia? A nested case control study
Pharmacoepidemiol Drug Saf
Tamoxifen and depression: More evidence from the National Surgical Adjuvant Breast and Bowel Project's Breast Cancer Prevention (P-1) randomized study
J Natl Cancer Lust
Health-related quality of life and tamoxifen in breast cancer prevention: A report from the National Surgical Adjuvant Breast and Bowel Project P-1study
J Clin Oncol
Risk of suicide among users of calcium channel blockers: Population based, nested case-control study
BMJ
The effect of raloxifene on cognitive function in postmenopausal women: A randomized clinical trial
Conn Med
Beta-blocker therapy and symptoms of depression, fatigue, and sexual dysfunction
JAMA
Serum cholesterol levels and suicide: A metaanalysis
Suicide Life Threat Behav
Psychiatric adverse events during vigabatrin therapy
Neurology
Use of computerized neuropsychological tests (CANTAB) to assess cognitive effects of antihypertensive drugs in the elderly. CambridgeNeuropsychological Test Automated Battery
J Hypertens
Cholesterol reduction and non-illness mortality: Meta-analysis of randomised clinical trials
BMJ
Randomized trial of adjuvant tamoxifen and/or goserelin in premenopausal breast cancer-self-rated physiological effects and symptoms
Acta Oncol
Cast control studies of cardiovascular medications as risk factors for clinically diagnosed depressive disorders in a hospitalized population
Can J Psychiatry
H2 blocker exposure as a risk factor for depression
Can J Psychiatry
Long-term assessment of psychological well-being in a randomized placebo-controlled trial of cholesterol reduction with pravastatin
Arch Intern Med
Randomised placebo controlled trial of effect on mood of lowering cholesterol concentration
BMJ
A randomized double-blind placebocontrolled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects
Int J Obes Relat Metab Disord
Cognitive function in postmenopausal women treated with raloxifene
N Engl J Med
Lipid-lowering drugs and the risk of depression and suicidal behavior
Arch Intern Med
Cited by (29)
Meta-review of depressive subtyping models
2012, Journal of Affective DisordersCitation Excerpt :A range of somatic diseases as well as several medications is viewed as capable of inducing depressive syndromes — and classifiable as a DSM-IV mood disorder due to a general medical condition with depressive features or a substance-induced mood disorder with depressive features. These comprise infectious conditions, rheumatoid arthritis, cancer, Alzheimer's disease, multiple sclerosis and other neurodegenerative diseases, vascular depression, post-stroke depression, and Cushing's syndrome as somatic conditions (Baldwin, 2005; Pucak et al., 2007; Pucak and Kaplin, 2005; Robinson and Spalletta, 2010; Samaras et al., 2010; Schiepers et al., 2005; Sonino et al., 2010; Tharwani et al., 2007) as well as medications, such as some β-blockers (propranolol, sotalol), corticosteroids, contraceptive implants, gonadotropin-releasing hormone antagonists, interferon-α, interleukin-2, 5-alpha-reduced steroids and mefloquine (Kotlyar et al., 2005; Patten and Barbui, 2004; Pucak and Kaplin, 2005; Römer and Gass, 2010; Schiepers et al., 2005). Depending on the particular condition or medication, the clinical presentation, psychopathological pathways and treatment options vary widely and partly differ from other subtypes of depression.
Depression in Later Life: An Overview with Treatment Recommendations
2012, Psychiatric Clinics of North AmericaCitation Excerpt :Because many older adults are prescribed multiple concurrent medications, it is imperative to rule out depression that is secondary to the use of pharmacologic agents. Antihypertensive agents such as reserpine, methyldopa, beta-blockers, clonidine, calcium channel blockers, and angiotensin-converting enzyme inhibitors have been associated with inducing depressed states.31 Because patients who are on these medications are likely to have cardiovascular disease independently associated with depression,32 there is controversy about whether these medications or the conditions they treat are more relevant to the induction of depressive symptoms.
Low Blood Pressure and Depressive Symptoms among Chinese Older Subjects: A Population-based Study
2010, American Journal of MedicineCitation Excerpt :For each chronic condition reported by the participants, information on drugs currently used was ascertained from the drug packet labels. This included antihypertensive drugs such as beta-blockers (propranolol, atenolol, bisoprolol), angiotensin-converting enzyme inhibitors, cardiovascular drugs (eg, thiazide diuretics, digoxin), and other drugs reported in the literature to have the potential to cause depression: corticosteroids (eg, prednisolone), hormone replacement therapy (eg, premarin), anti-Parkinsonism drugs (eg, L-dopa, benzhexol), neuroleptics and anti-anxiety drugs (eg, haloperodiol, risperidone, chloral hydrate, benzodiazepines), nonsteroidal anti-inflammatory drugs (eg, indomethacine, naproxen, tramodol, diclofenac, Vioxx), antineoplastic medications (eg, tamoxifen, methotrexate), and others (eg, cimetidine, ranitidine, famotidine).21,23 These were used to determine whether the participants were using more than 1 (≥2) antihypertensive medication or at least one other depression-causing drug.
Aetiology of late-life affective disorders
2018, Practical Management of Affective Disorders in Older People: A Multi-Professional Approach